{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:35:45Z","timestamp":1790678145830,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.2215\/cjn.11951214","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T12:24:44Z","timestamp":1435926284000},"page":"2279-2287","source":"Crossref","is-referenced-by-count":54,"title":["Human Heredity and Health (H3) in Africa Kidney Disease Research Network"],"prefix":"10.2215","volume":"10","author":[{"given":"Charlotte","family":"Osafo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemi Raheem","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bamidele O.","family":"Tayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicki","family":"Tiffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marva M.","family":"Moxey-Mims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah S.","family":"Rasooly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinlolu","family":"Ojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwomoa","family":"Adu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulan S.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20230601","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/S2214-109X(14)70002-6","article-title":"The epidemiology of chronic kidney disease in sub-Saharan Africa: A systematic review and meta-analysis.","volume":"2","author":"Stanifer","year":"2014","journal-title":"Lancet Glob Health"},{"key":"R2-23-20230601","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans.","volume":"40","author":"Kao","year":"2008","journal-title":"Nat Genet"},{"key":"R3-23-20230601","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"R4-23-20230601","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans.","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"R5-23-20230601","doi-asserted-by":"crossref","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1.","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-23-20230601","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations.","volume":"21","author":"Limou","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"R7-23-20230601","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1251546","article-title":"Research capacity. Enabling the genomic revolution in Africa.","volume":"344","author":"Rotimi","year":"2014","journal-title":"Science"},{"key":"R8-23-20230601","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States.","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"R9-23-20230601","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R10-23-20230601","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R12-23-20230601","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"R13-23-20230601","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R14-23-20230601","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","article-title":"The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.","volume":"14","author":"Feldman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R16-23-20230601","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrneph.2011.52","article-title":"The population genetics of chronic kidney disease: Insights from the MYH9-APOL1 locus.","volume":"7","author":"Rosset","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R17-23-20230601","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney Int"},{"key":"R18-23-20230601","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ki.2012.369","article-title":"Hypertension-misattributed kidney disease in African Americans.","volume":"83","author":"Skorecki","year":"2013","journal-title":"Kidney Int"},{"key":"R19-23-20230601","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease.","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"R20-23-20230601","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/modpathol.2014.92","article-title":"Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.","volume":"28","author":"Larsen","year":"2015","journal-title":"Mod Pathol"},{"key":"R21-23-20230601","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6939-13-15","article-title":"Seeking consent to genetic and genomic research in a rural Ghanaian setting: A qualitative study of the MalariaGEN experience.","volume":"13","author":"Tindana","year":"2012","journal-title":"BMC Med Ethics"},{"key":"R22-23-20230601","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1472-6939-15-76","article-title":"Ethical issues in the export, storage and reuse of human biological samples in biomedical research: Perspectives of key stakeholders in Ghana and Kenya.","volume":"15","author":"Tindana","year":"2014","journal-title":"BMC Med Ethics"},{"key":"R23-23-20230601","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40246-014-0018-7","article-title":"Informed consent and ethical re-use of African genomic data.","volume":"8","author":"Wright","year":"2014","journal-title":"Hum Genomics"},{"key":"R24-23-20230601","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tig.2014.11.004","article-title":"The H3Africa policy framework: Negotiating fairness in genomics.","volume":"31","author":"de Vries","year":"2015","journal-title":"Trends Genet"},{"key":"R25-23-20230601","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline characteristics and associations with kidney function.","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-23-20230601","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ndt\/gfu294","article-title":"Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort.","volume":"30","author":"Titze","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R27-23-20230601","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10157-010-0328-6","article-title":"Chronic Kidney Disease Japan Cohort study: Baseline characteristics and factors associated with causative diseases and renal function.","volume":"14","author":"Imai","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"R28-23-20230601","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2369-14-121","article-title":"Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).","volume":"14","author":"Levin","year":"2013","journal-title":"BMC Nephrol"},{"key":"R29-23-20230601","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2369-12-53","article-title":"Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: The MERENA observational cohort study.","volume":"12","author":"Mart\u00ednez-Castelao","year":"2011","journal-title":"BMC Nephrol"},{"key":"R30-23-20230601","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2215\/CJN.01780408","article-title":"Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.","volume":"4","author":"Wong","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R31-23-20230601","first-page":"178A","article-title":"Prevalence of chronic kidney disease and associated risk factors: first results from a population based screening program in Morocco (MAREMAR) Abstract.","volume":"23","author":"Gharbi","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R32-23-20230601","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201512000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:33Z","timestamp":1786369533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201512000-00023"}},"subtitle":["A Focus on Methods in Sub-Saharan Africa"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11951214","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}